Electroacupuncture may reduce hot flashes among breast cancer survivors
the ONA take:
Electroacupuncture may be more effective and safer than gabapentin for managing hot flashes among breast cancer survivors, according to a new study published online ahead of print in the Journal of Clinical Oncology.
For the study, researchers from the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA, and colleagues sought to compare the effects of electroacupuncture with gabapentin for hot flashes among breast cancer survivors.
Researchers enrolled 120 breast cancer survivors who were experiencing bothersome hot flashes at least twice per day day. Participants were randomly assigned to receive 8 weeks of electroacupuncture or gabapentin once daily with placebo acupuncture or pills.
Results showed that by week 8, patients in the electroacupuncture group experienced the greatest reduction in hot flash composite score, followed by placebo electroacupuncture, gabapentin, and placebo pills (P≤0.001).
In regard to safety, patients in the gabapentin group experienced the greatest amount of treatment-related adverse events, followed by placebo pills, electroacupuncture, and placebo electroacupuncture (P=0.005).
By week 24, electroacupuncture was still the most effective treatment for reducing hot flash composite score. The authors note that these findings need to be confirmed in a larger randomized controlled trial with long-term follow-up.
Electroacupuncture may be more effective and safer than gabapentin for managing hot flashes among breast cancer survivors.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|